Session I: EGFR

Moderator(s)

• 

  Corey Langer, MD, FACP

  Abramson Cancer Center, Hospital of the University of Pennsylvania

Presenter(s)

• 

  Lyudmila Bazhenova, MD

  University of California, San Diego
• 

  Jamie Chaft, MD

  Memorial Sloan Kettering Cancer Center
• 

  Jonathan Goldman, MD

  UCLA
• 

  Joel Neal, MD, PhD

  Stanford University Medical Center

Presentations:

• 9:00 AM – 9:10 AM

  Welcome Video
• 9:10 AM – 9:15 AM

  Welcome and Introduction; Pre-Session Audience Survey
  

  Co-Chair: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
• 9:15 AM – 9:35 AM

  Tissue vs Liquid vs Both: The Holy Grail of Diagnostics
  

  Speaker: Jonathan Goldman, MD – UCLA
• 9:35 AM – 9:55 AM

  EGFR: 1st Line, Second Line and Beyond in the Age of Osimertinib
  

  Speaker: Lyudmila Bazhenova, MD – University of California, San Diego
• 9:55 AM – 10:10 AM

  Exon 20 Mutations (the Other EGFR Target)
  

  Speaker: Joel W. Neal, MD, PhD – Stanford University Medical Center
• 10:10 AM – 10:20 AM

  Exporting EGFR TKIs to the Curative Setting
  

  Speaker: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center
• 10:20 AM – 10:45 AM

  Q&A; Post-Session Audience Survey
  

  Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

  Panelist: Lyudmila Bazhenova, MD – University of California, San Diego

  Panelist: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

  Panelist: Joel W. Neal, MD, PhD – Stanford University Medical Center

  Panelist: Jonathan Goldman, MD – UCLA